| Literature DB >> 20562191 |
Marjorie L McCullough1, Stephanie J Weinstein, D Michal Freedman, Kathy Helzlsouer, W Dana Flanders, Karen Koenig, Laurence Kolonel, Francine Laden, Loic Le Marchand, Mark Purdue, Kirk Snyder, Victoria L Stevens, Rachael Stolzenberg-Solomon, Jarmo Virtamo, Gong Yang, Kai Yu, Wei Zheng, Demetrius Albanes, Jason Ashby, Kimberly Bertrand, Hui Cai, Yu Chen, Lisa Gallicchio, Edward Giovannucci, Eric J Jacobs, Susan E Hankinson, Patricia Hartge, Virginia Hartmuller, Chinonye Harvey, Richard B Hayes, Ronald L Horst, Xiao-Ou Shu.
Abstract
Low vitamin D status is common globally and is associated with multiple disease outcomes. Understanding the correlates of vitamin D status will help guide clinical practice, research, and interpretation of studies. Correlates of circulating 25-hydroxyvitamin D (25(OH)D) concentrations measured in a single laboratory were examined in 4,723 cancer-free men and women from 10 cohorts participating in the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers, which covers a worldwide geographic area. Demographic and lifestyle characteristics were examined in relation to 25(OH)D using stepwise linear regression and polytomous logistic regression. The prevalence of 25(OH)D concentrations less than 25 nmol/L ranged from 3% to 36% across cohorts, and the prevalence of 25(OH)D concentrations less than 50 nmol/L ranged from 29% to 82%. Seasonal differences in circulating 25(OH)D were most marked among whites from northern latitudes. Statistically significant positive correlates of 25(OH)D included male sex, summer blood draw, vigorous physical activity, vitamin D intake, fish intake, multivitamin use, and calcium supplement use. Significant inverse correlates were body mass index, winter and spring blood draw, history of diabetes, sedentary behavior, smoking, and black race/ethnicity. Correlates varied somewhat within season, race/ethnicity, and sex. These findings help identify persons at risk for low vitamin D status for both clinical and research purposes.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20562191 PMCID: PMC2892536 DOI: 10.1093/aje/kwq113
Source DB: PubMed Journal: Am J Epidemiol ISSN: 0002-9262 Impact factor: 4.897
Characteristics (%) of Participants in the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers, by Cohort
| ATBC ( | CLUE II ( | CPS-II ( | HPFS ( | MEC ( | NHS ( | NYU-WHS ( | PLCO ( | SMHS ( | SWHS ( | Total ( | |
| Sex | |||||||||||
| Male | 100 | 35.3 | 46.5 | 100 | 51.9 | 0 | 0 | 48.4 | 100 | 0 | 45.2 |
| Female | 0 | 64.7 | 53.5 | 0 | 48.1 | 100 | 100 | 51.6 | 0 | 100 | 54.8 |
| Age at blood draw, years | |||||||||||
| ≤29 | 0 | 0.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 |
| 30–39 | 0 | 5.2 | 0 | 0 | 0 | 0 | 6.6 | 0 | 0 | 0 | 1.1 |
| 40–49 | 0.2 | 18.2 | 0 | 2.0 | 0 | 15.1 | 22.9 | 0 | 15.8 | 26.2 | 9.2 |
| 50–59 | 60.6 | 28.3 | 1.5 | 24.5 | 13.9 | 41.5 | 41.3 | 19.5 | 20.3 | 25.1 | 30.8 |
| 60–69 | 39.0 | 28.8 | 39.1 | 32.7 | 35.8 | 43.4 | 29.2 | 62.0 | 33.2 | 48.3 | 41.7 |
| 70–79 | 0.2 | 16.0 | 53.2 | 40.1 | 39.4 | 0 | 0 | 18.5 | 30.7 | 0.4 | 15.3 |
| 80–89 | 0 | 2.7 | 6.2 | 0.7 | 10.8 | 0 | 0 | 0 | 0 | 0 | 1.8 |
| Race/ethnicity | |||||||||||
| White | 100 | 99.8 | 98.0 | 93.9 | 12.5 | 98.3 | 72.2 | 92.6 | 0 | 0 | 72.3 |
| Black | 0 | 0.2 | 0.5 | 0 | 24.0 | 0.4 | 11.1 | 3.9 | 0 | 0 | 4.0 |
| Asian | 0 | 0 | 0.5 | 0.7 | 26.2 | 1.0 | 0.4 | 3.0 | 100 | 100 | 18.4 |
| Other | 0 | 0 | 1.0 | 2.0 | 37.3 | 0.2 | 4.4 | 0.5 | 0 | 0 | 4.0 |
| Missing data | 0 | 0 | 0 | 3.4 | 0 | 0 | 11.9 | 0 | 0 | 0 | 1.3 |
| Country of residence | |||||||||||
| United States | |||||||||||
| Northeast | 0 | 0 | 20.6 | 15.6 | 0 | 56.2 | 99.6 | 12.6 | 0 | 0 | 20.0 |
| Midwest | 0 | 0 | 29.9 | 34.7 | 0 | 19.3 | 0 | 55.2 | 0 | 0 | 14.8 |
| West | 0 | 0 | 25.4 | 26.5 | 100 | 12.8 | 0.2 | 21.2 | 0 | 0 | 16.7 |
| South | 0 | 100 | 24.1 | 22.4 | 0 | 11.7 | 0.2 | 11.1 | 0 | 0 | 15.2 |
| Finland | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.8 |
| China | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 100 | 15.4 |
| Latitude, degrees North | |||||||||||
| <35 | 0 | 0 | 20.9 | 25.9 | 97.4 | 13.4 | 0.4 | 6.8 | 100 | 100 | 29.1 |
| 35–42 | 0 | 100 | 52.2 | 42.2 | 2.6 | 56.4 | 99.6 | 46.5 | 0 | 0 | 38.9 |
| >42 | 100 | 0 | 26.9 | 32.0 | 0 | 30.2 | 0 | 46.7 | 0 | 0 | 32.0 |
| Year of blood draw | |||||||||||
| 1985–1989 | 100 | 100 | 0 | 0 | 0 | 38.4 | 96.8 | 0 | 0 | 0 | 40.8 |
| 1990–1994 | 0 | 0 | 0 | 94.6 | 1.2 | 61.6 | 3.2 | 14.5 | 0 | 0 | 12.0 |
| 1995–1999 | 0 | 0 | 38.6 | 5.4 | 25.5 | 0 | 0 | 80.0 | 0 | 94.3 | 29.6 |
| 2000–2004 | 0 | 0 | 61.4 | 0 | 71.4 | 0 | 0 | 5.5 | 80.2 | 5.7 | 16.5 |
| 2005 or later | 0 | 0 | 0 | 0 | 1.9 | 0 | 0 | 0 | 19.8 | 0 | 1.0 |
| Season of blood draw | |||||||||||
| Winter | 36.9 | 0 | 16.7 | 15.0 | 24.0 | 25.8 | 26.1 | 22.4 | 17.3 | 21.1 | 22.7 |
| Spring | 27.2 | 33.3 | 19.7 | 27.9 | 27.9 | 27.9 | 19.7 | 28.2 | 26.2 | 22.8 | 26.2 |
| Summer | 10.8 | 47.0 | 41.8 | 34.0 | 27.9 | 24.3 | 24.8 | 24.2 | 18.3 | 15.4 | 24.9 |
| Fall | 25.1 | 19.8 | 21.9 | 23.1 | 20.2 | 22.0 | 29.4 | 25.2 | 38.1 | 40.7 | 26.3 |
| 25-Hydroxyvitamin D, nmol/L | |||||||||||
| <25 | 36.2 | 3.8 | 4.2 | 2.7 | 11.3 | 5.7 | 12.7 | 4.2 | 18.8 | 24.9 | 14.4 |
| 25–<37.5 | 23.5 | 9.0 | 8.7 | 8.2 | 16.3 | 12.4 | 21.0 | 14.9 | 29.7 | 35.6 | 18.5 |
| 37.5–<50 | 16.6 | 16.2 | 19.2 | 21.1 | 22.1 | 24.5 | 23.1 | 24.7 | 25.2 | 21.9 | 21.2 |
| 50–<75 | 18.8 | 43.6 | 43.3 | 42.2 | 33.4 | 39.6 | 31.4 | 42.7 | 20.8 | 15.0 | 32.3 |
| 75–<100 | 4.2 | 20.0 | 18.4 | 19.7 | 12.5 | 14.0 | 10.0 | 10.3 | 5.0 | 2.7 | 10.6 |
| ≥100 | 0.7 | 7.4 | 6.2 | 6.1 | 4.3 | 3.8 | 1.9 | 3.3 | 0.5 | 0 | 3.1 |
Abbreviations: ATBC, Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study; CPS-II, Cancer Prevention Study II Nutrition Cohort; HPFS, Health Professionals Follow-Up Study; MEC, Multi-Ethnic Cohort Study; NHS, Nurses’ Health Study; NYU-WHS, New York University Women's Health Study; PLCO, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial; SMHS, Shanghai Men's Health Study; SWHS, Shanghai Women's Health Study.
Percentages do not total 100 for this cohort because of missing data.
Figure 1.Distribution of circulating 25-hydroxyvitamin D (25(OH)D) concentrations by country within the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. A) Distribution of circulating 25(OH)D concentrations among US men and women. Vertical lines represent a priori cutpoints of 25, 37.5, 50, 75, and 100 nmol/L. 25(OH)D concentrations in men were statistically significantly greater than those in women (P < 0.001). B) Distribution of circulating 25(OH)D concentrations among men and women in Shanghai, China. 25(OH)D concentrations in men were statistically significantly greater than those in women (P < 0.001). C) Distribution of circulating 25(OH)D concentrations among men in Finland.
Figure 2.Mean circulating 25-hydroxyvitamin D (25(OH)D) concentrations by race/ethnicity, season, and latitude within the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Circles represent mean values; bars represent the standard error. A) 25(OH)D concentrations among whites (n = 3,415) across seasons, within latitude categories of <35°N, 35°N–42°N, and >42°N. Differences in mean concentrations were statistically significant for all seasons at each latitude (for winter, spring, and fall, P < 0.001; for summer, P = 0.0082). Seasonal differences within latitude were also statistically significant: for <35°N, P = 0.017; for 35°N–42°N, P < 0.0001; and for >42°N, P < 0.0001. B) 25(OH)D concentrations among blacks (n = 188) across seasons, within latitude categories of <35°N and ≥35°N. Within-season 25(OH)D did not vary by latitude, but the difference within latitude across seasons was borderline-significant for latitude <35°N (P = 0.06), whereas no differences across season were noted for latitude ≥35°N (P = 0.94). C) 25(OH)D concentrations among Asians (n = 871) and persons of “other” race/ethnicity (n = 188) across seasons. The majority of Asians resided between 35°N latitude and 42°N latitude; statistically significant differences in 25(OH)D concentrations were observed across seasons (P < 0.0001). The majority of persons of “other” race/ethnicity resided at <35°N latitude; significant differences were observed by season (P = 0.03).
Distribution of Participant Characteristics According to A Priori 25-Hydroxyvitamin D Category in the Cohort Consortium Vitamin D Pooling Project of Rarer Cancersa
| No. of Participants | Mean Serum 25(OH)D, nmol/L | Serum 25(OH)D Category, nmol/L | ||||||
| <25 | 25–<37.5 | 37.5–<50 | 50–<75 | 75–<100 | ≥100 | |||
| Age at blood draw, years | 58.9 | 59.7 | 61.1 | 62.1 | 62.0 | 61.6 | ||
| Body mass index | 26.2 | 26.2 | 26.4 | 25.8 | 25.2 | 24.5 | ||
| Vitamin D intake, IU/day | 139 | 164 | 204 | 219 | 242 | 239 | ||
| Dietary calcium intake, mg/day | 932 | 890 | 938 | 966 | 1,011 | 965 | ||
| Milk intake, g/day | 323 | 237 | 254 | 265 | 278 | 293 | ||
| Fish intake, g/day | 32 | 34 | 34 | 32 | 30 | 30 | ||
| Sex | ||||||||
| Male | 2,135 | 49.2 | 18 | 17 | 20 | 32 | 10 | 3 |
| Female | 2,588 | 50.4 | 12 | 20 | 22 | 33 | 11 | 3 |
| Race/ethnicity | ||||||||
| White | 3,415 | 52.6 | 13 | 15 | 21 | 36 | 12 | 4 |
| Black | 188 | 41.1 | 27 | 26 | 19 | 19 | 5 | 3 |
| Asian | 871 | 41.1 | 20 | 31 | 23 | 21 | 5 | 1 |
| Other | 188 | 51.7 | 8 | 18 | 22 | 38 | 11 | 2 |
| Education | ||||||||
| Less than high school | 1,010 | 41.6 | 24 | 25 | 21 | 24 | 5 | 2 |
| Completion of high school | 852 | 51.7 | 11 | 20 | 21 | 33 | 12 | 3 |
| Vocational school | 545 | 41.8 | 24 | 23 | 21 | 23 | 6 | 2 |
| Some college | 1,104 | 52.2 | 12 | 17 | 20 | 36 | 12 | 3 |
| College graduation | 517 | 56.5 | 7 | 11 | 24 | 39 | 14 | 4 |
| Graduate study | 617 | 58.9 | 5 | 11 | 22 | 42 | 16 | 5 |
| Season of blood draw | ||||||||
| Fall | 1,240 | 48.8 | 14 | 20 | 22 | 32 | 10 | 2 |
| Winter | 1,070 | 40.8 | 26 | 23 | 21 | 23 | 6 | 1 |
| Spring | 1,236 | 48.5 | 15 | 21 | 21 | 30 | 10 | 3 |
| Summer | 1,175 | 60.7 | 4 | 10 | 20 | 43 | 16 | 7 |
| Body mass index category | ||||||||
| <25 | 2,178 | 51.4 | 14 | 18 | 20 | 32 | 12 | 4 |
| 25–<30 | 1,799 | 49.6 | 14 | 18 | 22 | 33 | 10 | 3 |
| ≥30 | 717 | 45.6 | 16 | 21 | 24 | 29 | 8 | 1 |
| Physical activity | ||||||||
| Sedentary | 1,548 | 44.2 | 20 | 23 | 22 | 26 | 8 | 1 |
| Light activity | 1,190 | 49.1 | 15 | 17 | 22 | 34 | 10 | 3 |
| Moderate activity | 783 | 52.4 | 9 | 18 | 22 | 37 | 11 | 3 |
| Vigorous activity | 935 | 56.0 | 10 | 15 | 19 | 35 | 15 | 6 |
| History of diabetes | ||||||||
| No | 4,352 | 50.2 | 14 | 18 | 21 | 32 | 11 | 3 |
| Yes | 277 | 44.0 | 16 | 29 | 20 | 29 | 5 | 2 |
| History of hypertension | ||||||||
| No | 3,308 | 50.2 | 15 | 18 | 20 | 33 | 11 | 3 |
| Yes | 1,357 | 49.1 | 13 | 19 | 24 | 32 | 9 | 3 |
| Hormone replacement therapy (women only) | ||||||||
| No current use | 2,018 | 49.7 | 13 | 21 | 22 | 31 | 11 | 3 |
| Current use | 469 | 56.2 | 5 | 14 | 23 | 40 | 13 | 4 |
| Smoking status | ||||||||
| Never smoker | 2,016 | 51.0 | 12 | 19 | 22 | 33 | 12 | 3 |
| Former smoker | 1,380 | 57.2 | 5 | 13 | 23 | 41 | 14 | 5 |
| Current smoker | 1,245 | 39.6 | 29 | 24 | 18 | 22 | 5 | 2 |
| Alcohol use | ||||||||
| No current use | 1,938 | 47.1 | 16 | 22 | 22 | 29 | 9 | 3 |
| Current use | 2,470 | 51.9 | 13 | 16 | 21 | 35 | 12 | 3 |
| Supplemental calcium use | ||||||||
| No current use | 2,801 | 49.5 | 16 | 18 | 20 | 32 | 10 | 3 |
| Current use | 793 | 58.1 | 6 | 10 | 23 | 40 | 16 | 4 |
| Multivitamin use | ||||||||
| No current use | 2,468 | 49.9 | 12 | 20 | 23 | 32 | 10 | 3 |
| Current use | 1,089 | 59.5 | 4 | 11 | 20 | 42 | 17 | 5 |
| Dietary vitamin D intake, quintile of IU/day | ||||||||
| Quintile 1 | 753 | 40.8 | 24 | 18 | 18 | 28 | 8 | 3 |
| Quintile 2 | 753 | 47.0 | 14 | 18 | 19 | 35 | 11 | 3 |
| Quintile 3 | 752 | 50.2 | 11 | 16 | 22 | 36 | 11 | 3 |
| Quintile 4 | 753 | 53.4 | 9 | 15 | 22 | 36 | 14 | 4 |
| Quintile 5 | 752 | 57.7 | 5 | 11 | 22 | 40 | 17 | 4 |
Abbreviation: 25(OH)D, 25-hydroxyvitamin D.
Summary statistics shown are unadjusted.
Weight (kg)/height (m)2.
Variables Associated With Circulating 25-Hydroxyvitamin D Concentrations (nmol/L) Among Controls in Stepwise Regression Models, Overall and by Sex and Race/Ethnicity, Cohort Consortium Vitamin D Pooling Project of Rarer Cancersa
| Total | Sex | Race/Ethnicity | ||||||||||
| Male | Female | White | Black | Asian | ||||||||
| β | β | β | β | β | β | |||||||
| No. of controls | 4,465 | 2,023 | 2,449 | 3,203 | 181 | 867 | ||||||
| Adjusted | 0.30 | 0.36 | 0.26 | 0.29 | 0.23 | 0.31 | ||||||
| Male sex (vs. female) | 7.85 | <0.001 | 8.20 | <0.001 | 14.70 | <0.001 | 9.01 | 0.01 | ||||
| Race/ethnicity | <0.0001 | 0.0001 | <0.0001 | |||||||||
| White (referent) | ||||||||||||
| Other | −6.08 | 0.004 | −7.15 | 0.04 | −4.74 | 0.08 | ||||||
| Black | −13.53 | <0.001 | −11.00 | 0.001 | −14.86 | <0.001 | ||||||
| Asian | −0.45 | 0.837 | 4.37 | 0.18 | −5.12 | 0.10 | ||||||
| Season of blood draw | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.26 | <0.0001 | ||||||
| Fall (referent) | ||||||||||||
| Winter | −7.13 | <0.001 | −7.89 | <0.001 | −6.31 | <0.001 | −7.54 | <0.001 | 4.27 | 0.40 | −8.73 | <0.001 |
| Spring | −2.18 | 0.010 | −2.45 | 0.05 | −1.98 | 0.08 | −1.90 | 0.07 | 5.60 | 0.24 | −3.96 | 0.01 |
| Summer | 6.80 | <0.001 | 8.72 | <0.001 | 6.02 | <0.001 | 6.88 | <0.001 | 9.38 | 0.048 | 8.52 | <0.001 |
| Body mass index | ||||||||||||
| Continuous | −0.54 | <0.001 | −0.74 | <0.001 | ||||||||
| Categorical | 0.07 | <0.0001 | ||||||||||
| <25 (referent) | ||||||||||||
| 25–<30 | −0.43 | 0.67 | −2.37 | 0.004 | ||||||||
| ≥30 | −2.96 | 0.04 | −7.02 | <0.001 | ||||||||
| Physical activity | <0.0001 | 0.002 | <0.0001 | |||||||||
| Sedentary | −1.49 | 0.08 | −1.83 | 0.11 | −1.23 | 0.20 | ||||||
| Light activity (referent) | ||||||||||||
| Moderate activity | 0.50 | 0.62 | 0.15 | 0.93 | 0.59 | 0.62 | ||||||
| Vigorous activity | 3.37 | <0.001 | 3.99 | 0.01 | 5.07 | <0.001 | ||||||
| History of diabetes (yes vs. no) | −3.67 | 0.005 | −3.20 | 0.07 | −4.14 | 0.04 | −5.29 | 0.003 | ||||
| Smoking status | 0.02 | 0.001 | 0.03 | 0.03 | ||||||||
| Never smoker (referent) | ||||||||||||
| Former smoker | 0.05 | 0.95 | 0.83 | 0.41 | 0.75 | 0.42 | −2.70 | 0.24 | ||||
| Current smoker | −3.63 | 0.003 | −5.32 | <0.001 | −3.76 | 0.02 | −5.31 | 0.01 | ||||
| Current alcohol use (vs. no current use) | 2.46 | 0.001 | 3.23 | 0.01 | 1.91 | 0.06 | 2.43 | 0.01 | 3.72 | 0.07 | ||
| Dietary calcium intake (per 100 mg) | −0.3 | 0.01 | 1.9 | 0.003 | −0.7 | 0.04 | ||||||
| Dietary vitamin D intake (per 100 IU) | 1.8 | <0.001 | 3.5 | <0.001 | 1.8 | <0.001 | −3.1 | 0.01 | ||||
| Milk intake (per cup (237 mL)) | 2.16 | <0.001 | ||||||||||
| Fish intake (per ounce (28.4 g)) | 0.78 | 0.02 | 0.93 | 0.03 | ||||||||
| Current use of calcium supplements (vs. no current use) | 4.88 | <0.001 | 4.93 | <0.001 | 5.87 | <0.001 | 5.71 | <0.001 | ||||
| Current use of multivitamins (vs. no current use) | 3.65 | <0.001 | 5.69 | <0.001 | 3.67 | <0.001 | 17.56 | <0.001 | ||||
Results were adjusted for age, and cohort.
P value for categorical variable.
Weight (kg)/height (m)2.
Variables Associated With Circulating 25-Hydroxyvitamin D Concentrations (nmol/L) Among Controls in Stepwise Regression Models According to Season of Blood Draw, Cohort Consortium Vitamin D Pooling Project of Rarer Cancersa
| Season of Blood Draw | ||||||||
| Winter | Spring | Summer | Fall | |||||
| β | β | β | β | |||||
| No. of controls | 1,015 | 1,178 | 1,096 | 1,188 | ||||
| Adjusted | 0.32 | 0.28 | 0.16 | 0.25 | ||||
| Male sex (vs. female) | 5.72 | 0.01 | 6.93 | <0.001 | 8.98 | <0.001 | 4.04 | 0.046 |
| Race/ethnicity | 0.03 | <0.001 | <0.001 | <0.001 | ||||
| White (referent) | ||||||||
| Other | −5.85 | 0.14 | −5.35 | 0.17 | −11.51 | 0.01 | 3.92 | 0.38 |
| Black | −11.12 | 0.003 | −9.23 | 0.01 | −15.21 | <0.001 | −16.93 | <0.001 |
| Asian | −3.06 | 0.46 | 8.96 | 0.05 | −6.03 | 0.15 | 3.20 | 0.49 |
| Education | 0.13 | |||||||
| Less than high school | −3.35 | 0.21 | ||||||
| Completion of high school | −4.82 | 0.05 | ||||||
| Vocational school | −4.38 | 0.11 | ||||||
| Some college | −0.55 | 0.81 | ||||||
| College graduation | −2.89 | 0.27 | ||||||
| Graduate study (referent) | ||||||||
| Body mass index | ||||||||
| Continuous | −0.63 | <0.001 | −0.74 | <0.001 | ||||
| Categorical | 0.002 | 0.002 | ||||||
| <25 (referent) | ||||||||
| 25–<30 | −2.13 | 0.11 | −1.00 | 0.44 | ||||
| ≥30 | −6.80 | <0.001 | −7.13 | <0.001 | ||||
| History of diabetes (yes vs. no) | −5.30 | 0.04 | −5.08 | 0.10 | −5.51 | 0.02 | ||
| Smoking status | 0.26 | 0.02 | 0.002 | |||||
| Never smoker (referent) | ||||||||
| Former smoker | −0.57 | 0.72 | 0.59 | 0.70 | 0.47 | 0.77 | ||
| Current smoker | −4.99 | 0.047 | −5.95 | 0.01 | −8.56 | <0.001 | ||
| Current alcohol use (vs. no current use) | 2.65 | 0.06 | 3.86 | 0.02 | 3.31 | 0.03 | ||
| Dietary vitamin D intake (per 100 IU) | 2.3 | <0.001 | 2.2 | <0.001 | 2.0 | <0.001 | 1.2 | 0.03 |
| Fish intake (per ounce (28.4 g)) | 2.01 | 0.002 | ||||||
| Current use of multivitamins (vs. no current use) | 5.03 | 0.003 | 7.38 | <0.001 | 5.76 | 0.01 | ||
Results were additionally adjusted for age and cohort.
P value for categorical variable.
Weight (kg)/height (m)2.
Odds Ratios for the Association Between Selected Covariates and Circulating 25-Hydroxyvitamin D Concentrations, Cohort Consortium Vitamin D Pooling Project of Rarer Cancersa
| Serum 25-Hydroxyvitamin D Category | ||||||
| <25 | 25–<50 | ≥75 | ||||
| OR | 95% CI | OR | 95% CI | OR | 95 CI | |
| Sex | ||||||
| Male | 1.00 | Referent | 1.00 | Referent | 1.00 | Referent |
| Female | 4.15 | 2.57, 6.70 | 1.70 | 1.36, 2.12 | 0.79 | 0.61, 1.03 |
| Race/ethnicity | ||||||
| White | 1.00 | Referent | 1.00 | Referent | 1.00 | Referent |
| Black | 9.17 | 4.90, 17.18 | 2.53 | 1.60, 4.00 | 0.83 | 0.42, 1.64 |
| Asian | 0.25 | 0.07, 0.94 | 0.97 | 0.59, 1.59 | 0.74 | 0.40, 1.36 |
| Other | 1.00 | 0.44, 2.27 | 1.10 | 0.69, 1.77 | 0.51 | 0.27, 0.96 |
| Season of blood draw | ||||||
| Fall | 1.00 | Referent | 1.00 | Referent | 1.00 | Referent |
| Winter | 3.23 | 2.43, 4.30 | 1.66 | 1.34, 2.06 | 0.83 | 0.60, 1.15 |
| Spring | 1.62 | 1.22, 2.14 | 1.23 | 1.01, 1.50 | 1.04 | 0.80, 1.37 |
| Summer | 0.31 | 0.21, 0.46 | 0.65 | 0.54, 0.80 | 1.22 | 0.95, 1.56 |
| Body mass index | ||||||
| <25 | 1.00 | Referent | 1.00 | Referent | 1.00 | Referent |
| 25–<30 | 1.04 | 0.83, 1.32 | 1.10 | 0.94, 1.30 | 0.78 | 0.63, 0.95 |
| ≥30 | 1.82 | 1.32, 2.50 | 1.60 | 1.29, 1.99 | 0.58 | 0.42, 0.80 |
| Physical activity | ||||||
| Sedentary | 1.49 | 1.12, 1.98 | 1.16 | 0.95, 1.42 | 1.07 | 0.80, 1.41 |
| Light activity | 1.00 | Referent | 1.00 | Referent | 1.00 | Referent |
| Moderate activity | 0.90 | 0.61, 1.31 | 0.95 | 0.76, 1.19 | 1.01 | 0.74, 1.36 |
| Vigorous activity | 1.12 | 0.79, 1.61 | 0.85 | 0.68, 1.06 | 1.61 | 1.23, 2.12 |
| Alcohol use | ||||||
| No current use | 1.00 | Referent | 1.00 | Referent | 1.00 | Referent |
| Current use | 0.61 | 0.46, 0.80 | 0.90 | 0.75, 1.07 | 1.07 | 0.86, 1.34 |
| Dietary vitamin D intake, quintile of IU/day | ||||||
| Quintile 1 | 4.67 | 3.12, 7.00 | 1.63 | 1.24, 2.14 | 0.63 | 0.43, 0.92 |
| Quintile 2 | 3.28 | 2.23, 4.84 | 1.35 | 1.05, 1.73 | 0.70 | 0.51, 0.96 |
| Quintile 3 | 2.12 | 1.43, 3.16 | 1.30 | 1.02, 1.65 | 0.71 | 0.52, 0.95 |
| Quintile 4 | 1.40 | 0.93, 2.12 | 1.27 | 1.01, 1.61 | 0.74 | 0.56, 0.99 |
| Quintile 5 | 1.00 | Referent | 1.00 | Referent | 1.00 | Referent |
| Supplemental calcium use | ||||||
| No current use | 1.00 | Referent | 1.00 | Referent | 1.00 | Referent |
| Current use | 0.38 | 0.26, 0.56 | 0.76 | 0.61, 0.94 | 1.31 | 1.01, 1.70 |
| Multivitamin use | ||||||
| No current use | 1.00 | Referent | 1.00 | Referent | 1.00 | Referent |
| Current use | 0.47 | 0.31, 0.70 | 0.71 | 0.58, 0.86 | 1.19 | 0.94, 1.50 |
Abbreviations: CI, confidence interval; OR, odds ratio.
Results from a polytomous logistic regression model with mutual adjustment for the variables shown. Results were additionally adjusted for age and cohort.
Reference category: 50–<75 nmol/L.
Weight (kg)/height (m)2.